Perbak Capital Partners LLP Increases Stake in Revvity Inc. $RVTY

Perbak Capital Partners LLP lifted its position in Revvity Inc. (NYSE:RVTY) by 191.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,545 shares of the company’s stock after acquiring an additional 10,877 shares during the quarter. Perbak Capital Partners LLP’s holdings in Revvity were worth $1,450,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in RVTY. New York Life Investment Management LLC lifted its position in shares of Revvity by 72.7% in the 3rd quarter. New York Life Investment Management LLC now owns 27,520 shares of the company’s stock worth $2,412,000 after purchasing an additional 11,583 shares during the period. Campbell & CO Investment Adviser LLC bought a new position in shares of Revvity during the third quarter valued at approximately $905,000. Amundi increased its holdings in Revvity by 157.0% during the second quarter. Amundi now owns 519,987 shares of the company’s stock valued at $52,467,000 after buying an additional 317,643 shares during the period. Invesco Ltd. increased its holdings in Revvity by 25.8% during the second quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock valued at $213,481,000 after buying an additional 452,343 shares during the period. Finally, SG Americas Securities LLC raised its stake in Revvity by 531.8% in the third quarter. SG Americas Securities LLC now owns 42,947 shares of the company’s stock worth $3,764,000 after buying an additional 36,149 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Trading Up 1.0%

NYSE:RVTY opened at $85.60 on Friday. The company has a market capitalization of $9.57 billion, a P/E ratio of 41.15, a PEG ratio of 1.80 and a beta of 1.10. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $118.30. The firm has a fifty day simple moving average of $102.27 and a 200-day simple moving average of $96.50.

Revvity (NYSE:RVTY) last released its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.15. The firm had revenue of $772.06 million for the quarter, compared to the consensus estimate of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm’s revenue was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, equities research analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is currently 13.46%.

Analysts Set New Price Targets

A number of analysts have weighed in on RVTY shares. Bank of America lowered Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a report on Monday, December 15th. Jefferies Financial Group lifted their price target on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Wall Street Zen raised Revvity from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Robert W. Baird set a $129.00 price objective on Revvity in a research note on Tuesday, February 3rd. Finally, TD Cowen reiterated a “hold” rating on shares of Revvity in a research note on Tuesday, February 3rd. Five equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $113.67.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.